Stem cell-derived exosomes as a potential therapy for schistosomal hepatic fibrosis in experimental animals

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Ellakany A.R.; El Baz H.; Shoheib Z.S.; Elzallat M.; Ashour D.S.; Yassen N.A.

Journal: Pathogens and Global Health

Publisher: Taylor and Francis Ltd.

Publication Date: 30 July 2023

Volume / Issue: Volume 118 / Issue 5

Pages: 429–449

ISSN: 20477724

DOI: 10.1080/20477724.2023.2240085

Scopus: View on Scopus

PubMed: 37519008

Document Type: Article

Access: All Open Access; Green Open Access


Authors and Affiliations

Ellakany A.R., Medical Parasitology Department, Faculty of Medicine, Tanta University, Tanta, Egypt; El Baz H., Immunology Department, Theodor Bilharz Research Institute, Cairo, Egypt; Shoheib Z.S., Medical Parasitology Department, Faculty of Medicine, Tanta University, Tanta, Egypt; Elzallat M., Immunology Department, Theodor Bilharz Research Institute, Cairo, Egypt; Ashour D.S., Medical Parasitology Department, Faculty of Medicine, Tanta University, Tanta, Egypt; Yassen N.A., Medical Parasitology Department, Faculty of Medicine, Tanta University, Tanta, Egypt


Abstract

Schistosomiasis is a neglected tropical disease. Egg-induced granuloma formation and tissue fibrosis are the main causes of the high morbidity and mortality of schistosomiasis. Mesenchymal stem cells (MSCs)-derived exosomes play an important role with a superior safety profile than MSCs in the treatment of liver fibrosis. Therefore, the aim of this study was to investigate the potential therapeutic effect of MSCs-derived exosomes on schistosomal hepatic fibrosis. Exosomes were isolated from bone marrow MSCs and characterized. A total of 85 mice were divided into four groups: group I (control group), group II (PZQ group) infected and treated with PZQ, group III (EXO group) infected and treated with MSCs-derived exosomes and group IV (PZQ+EXO group) infected and treated with both PZQ and MSCs-derived exosomes. Assessment of treatment efficacy was evaluated by histopathological and immunohistochemical examination of liver sections by proliferating cell nuclear antigen (PCNA) and nuclear factor-κB (NF-κB). The results showed significant reduction of the number and diameter of hepatic granulomas, hepatic fibrosis, upregulation of PCNA expression and reduction of NF-κB expression in EXO and PZQ+EXO groups as compared to other groups at all durations post infection. Additionally, more improvement was observed in PZQ+EXO group. In conclusion, MSCs-derived exosomes are a promising agent for the treatment of schistosomal hepatic fibrosis, and their combination with PZQ shows a synergistic action including antifibrotic and anti-inflammatory effects. However, further studies are required to establish their functional components and their mechanisms of action. © 2023 Informa UK Limited, trading as Taylor & Francis Group.


Keywords

beads-based flow cytometry; liver fibrosis; NF-κB; PCNA; Schistosomiasis; stem cell-derived exosomes; Animals; Disease Models, Animal; Exosomes; Female; Liver; Liver Cirrhosis; Male; Mesenchymal Stem Cells; Mice; NF-kappa B; Praziquantel; Proliferating Cell Nuclear Antigen; Treatment Outcome; cycline; immunoglobulin enhancer binding protein; animal experiment; animal model; animal tissue; apoptosis; Article; cell infiltration; cell proliferation; cell viability; chondrocyte; controlled study; exosome; histopathology; immunophenotyping; immunoreactivity; mesenchymal stem cell; mouse; MTT assay; nonhuman; photon correlation spectroscopy; protein expression; real time polymerase chain reaction; ultracentrifugation; animal; disease model; metabolism; parasitology; pathology; therapy; transplantation


Citation Information

Scopus Citations: 6


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]